Fertility tourism market set to reach $3.5B by 2030

The global fertility tourism market is projected to jump from $0.96 billion in 2025 to $1.24 billion in 2026, then reach $3.5 billion by 2030, according to a new Business Research Company report. Rising infertility rates, wider IVF and surrogacy access, and more health insurance coverage are helping drive cross-border demand.

Why it matters: - Fertility tourism is moving from a niche travel category to a faster-growing part of the medical tourism market. - The trend reflects rising demand for assisted reproductive technologies, lower-cost care abroad and access to treatments restricted at home. - The market’s projected growth suggests more clinics, brokers and digital platforms will compete for cross-border fertility patients.

What happened: - The Business Research Company released a report on the fertility tourism market covering 2026 through 2035. - The market is estimated at $0.96 billion in 2025 and is projected to reach $1.24 billion in 2026. - The report forecasts the market will grow to $3.5 billion by 2030. - Europe held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - The report pegs 2026 growth at a 29.9% compound annual growth rate, then forecasts a 29.5% CAGR through 2030. - Growth drivers include rising infertility rates, greater awareness of assisted reproductive technologies, legalization of IVF and surrogacy in some countries, and improved fertility clinic services. - Medical tourism infrastructure is also supporting demand. - Fertility tourism includes travel to another country or jurisdiction for IVF, surrogacy and other assisted reproductive treatments. - Patients often seek care abroad to avoid legal limits, lower out-of-pocket costs or reach specialist care unavailable at home. - The report says expanding cross-border reproductive care networks and more affordable treatment options are supporting future growth. - Other expected drivers include broader acceptance of diverse family models, streamlined rules in fertility destinations and wider use of digital consultation platforms. - Expected trends include remote diagnostics, AI-driven embryo selection, reproductive analytics, international surrogacy and donor matching networks, financing plans and insurance-linked reproductive coverage. - The report also highlights a preference for specialized fertility clinics with advanced assisted reproductive technology. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report includes market attractiveness scoring, total addressable market analysis, company scoring matrices, Excel dashboards, hotspot infographics and updated graphics and tables.

Between the lines: - Health insurance coverage is becoming a bigger enabler of fertility tourism because it can offset diagnosis, treatment, hospitalization and specialty-care costs. - In September 2025, US Census Bureau data showed private health insurance coverage in the U.S. rose 0.7% between 2023 and 2024, driven largely by direct-purchase plans. - Wider insurance access can make cross-border fertility care more financially reachable for patients who would otherwise delay treatment. - The report’s emphasis on digital consultations and remote diagnostics points to a more hybrid fertility-care model, where travel may be paired with virtual screening and follow-up.

What’s next: - The Business Research Company expects cross-border fertility networks, financing products and digital care tools to keep expanding through 2030. - More patients are likely to compare clinics internationally based on cost, regulation, technology and access to donor or surrogacy services. - More information is available in the sample report. - The full report is available online.

The bottom line: - Fertility tourism is entering a high-growth phase as medical, legal and financial barriers at home push more patients to seek treatment abroad.